Fifth Third Bancorp Amgen Inc Transaction History

Fifth Third Bancorp

$27.3 Billion
Q3 2024

A detailed history of Fifth Third Bancorp transactions in Amgen Inc stock. As of the latest transaction made, Fifth Third Bancorp holds 349,057 shares of AMGN stock, worth $94 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

349,057

Previous 345,978 0.89%

Holding current value

$94 Million

Previous $108 Million 4.04%

% of portfolio

0.41%

Previous 0.41%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$309.38 - $337.38 $952,581 - $1.04 Million	3,079 Added 0.89%	349,057 $112 Million
Q2 2024 Jul 22, 2024	BUY	$262.75 - $319.31 $2.09 Million - $2.54 Million	7,955 Added 2.35%	345,978 $108 Million
Q1 2024 Apr 23, 2024	BUY	$268.87 - $324.56 $1.07 Million - $1.29 Million	3,970 Added 1.19%	338,023 $96.1 Million
Q4 2023 Jan 19, 2024	BUY	$255.7 - $288.46 $1.01 Million - $1.14 Million	3,953 Added 1.2%	334,053 $96.2 Million
Q3 2023 Oct 31, 2023	BUY	$218.65 - $271.46 $2.89 Million - $3.59 Million	13,211 Added 4.17%	330,100 $88.7 Million
Q2 2023 Jul 25, 2023	SELL	$214.27 - $253.37 $2.6 Million - $3.08 Million	-12,149 Reduced 3.69%	316,889 $70.4 Million
Q1 2023 Apr 24, 2023	SELL	$225.79 - $275.2 $964,800 - $1.18 Million	-4,273 Reduced 1.28%	329,038 $79.5 Million
Q4 2022 Jan 25, 2023	BUY	$229.03 - $291.01 $405,154 - $514,796	1,769 Added 0.53%	333,311 $0
Q3 2022 Oct 25, 2022	SELL	$224.46 - $253.15 $2.15 Million - $2.42 Million	-9,564 Reduced 2.8%	331,542 $74.7 Million
Q2 2022 Aug 04, 2022	BUY	$230.71 - $256.74 $3.01 Million - $3.35 Million	13,043 Added 3.98%	341,106 $83 Million
Q1 2022 Apr 19, 2022	SELL	$219.27 - $242.57 $2.53 Million - $2.8 Million	-11,559 Reduced 3.4%	328,063 $79.3 Million
Q4 2021 Feb 01, 2022	SELL	$198.88 - $227.6 $1.16 Million - $1.33 Million	-5,832 Reduced 1.69%	339,622 $76.4 Million
Q3 2021 Oct 15, 2021	SELL	$212.27 - $248.7 $4.53 Million - $5.31 Million	-21,331 Reduced 5.82%	345,454 $73.5 Million
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $9.66 Million - $10.7 Million	-41,363 Reduced 10.13%	366,785 $89.4 Million
Q1 2021 May 07, 2021	SELL	$221.91 - $258.6 $6.06 Million - $7.06 Million	-27,317 Reduced 6.27%	408,148 $102 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $198,853 - $236,798	919 Added 0.21%	435,465 $100 Million
Q3 2020 Nov 09, 2020	BUY	$234.65 - $260.95 $338,365 - $376,289	1,442 Added 0.33%	434,546 $110 Million
Q2 2020 Aug 05, 2020	SELL	$197.81 - $242.74 $658,311 - $807,838	-3,328 Reduced 0.76%	433,104 $102 Million
Q1 2020 May 05, 2020	BUY	$182.24 - $241.7 $1.11 Million - $1.47 Million	6,089 Added 1.41%	436,432 $88.5 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $362,904 - $466,457	1,918 Added 0.45%	430,343 $104 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $2.05 Million - $2.46 Million	-11,776 Reduced 2.68%	428,425 $82.9 Million
Q2 2019 Aug 07, 2019	SELL	$166.7 - $195.41 $5.86 Million - $6.87 Million	-35,155 Reduced 7.4%	440,201 $81.1 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $3.03 Million - $3.42 Million	-16,774 Reduced 3.41%	475,356 $90.3 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $3.13 Million - $3.65 Million	17,547 Added 3.7%	492,130 $95.8 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $987,039 - $1.11 Million	-5,327 Reduced 1.11%	474,583 $98.4 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $3.16 Million - $3.55 Million	-19,035 Reduced 3.82%	479,910 $88.6 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $181,967 - $212,652	-1,074 Reduced 0.21%	498,945 $85.1 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $235,293 - $262,894	-1,394 Reduced 0.28%	500,019 $87 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $1.69 Million - $1.93 Million	10,083 Added 2.05%	501,413 $93.5 Million
Q2 2017 Aug 11, 2017	BUY	N/A	491,330	491,330 $84.6 Million

Others Institutions Holding AMGN

# of Institutions

3,100

Shares Held

406M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $144B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Amgen Inc Transaction History